WARNING: CannTrust (TSX:TRST) Could Be De-listed From the TSX. Avoid This Stock!

No matter how forgiving you might feel with the New Year around the corner, CannTrust is a stock you should avoid like the plague right now.

You Should Know This

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

With holiday season approaching, you might want to take a good look at your investment portfolio to see what you can do to change things up a little bit. A lot has happened over the past 12 months, with the legal cannabis sector, which was legalized in October 2018, being a particular area of investors’ interest.

The legal marijuana industry showed a lot of promise, but it hit quite a few snags on its way. The entire sector is down by a significant margin since its all-time highs some time back. One of the notable incidents that rocked the whole industry is the scandal involving CannTrust Holdings (TSX:TRST)(NYSE:CTST).

What happened?

If you do not know about it already, I will give you a precise account of what happened. Regulatory bodies like Health Canada regulate the legal cannabis industry. Authorities want to make sure that all of the products entering the market to reach consumers are controlled, safe, and compliant with legal and health standards.

The reason the illegal industry continues to boom is that it faces no regulatory restrictions or quality control standards. Unlicensed sellers can sell their goods at lower prices, affecting the legal industry’s market share by a significant margin.

Enter CannTrust Holdings as the would-be saviour of the legal marijuana industry. In an attempt to revitalize its line of products, the company was growing black market weed in secret rooms within its facilities. CannTrust got caught in the act, so it is safe to say that many people do not trust CannTrust anymore. The CEO was fired, regulators have been busy scrutinizing the company’s financial documents, and now exchanges are threatening to take the company’s stocks off the board.

CannTrust might be down and out

In light of the scandal, Health Canada allowed the company to make amends for its actions. Regulatory bodies have offered CannTrust until March 25, 2020, to file its audited financial restatements for the year 2018. If the company fails to do so, the Toronto Stock Exchange might finally de-list CannTrust. Trading at $1.03 per share, TRST stock might end up amounting to nothing at all.

A financial restatement is something that publicly traded companies need to file when authorities find a company conducting questionable activity and misreporting its financial data. The trouble started for CannTrust when regulators discovered secret grow rooms in its facilities towards the end of 2018.

Health Canada suspended CannTrust’s licence to produce and distribute marijuana in October 2019. The company also lost $77 million, as it had to discard inventory since it was not possible to determine how much of it was even legally grown. To save money, the company ended up laying off around 140 employees.

Foolish takeaway

There is very little I should need to say about CannTrust in light of all this information. CannTrust announced on November 26, 2019, that the TSX might de-list its shares. If you own any shares of the company even now, my advice would be to take whatever you have left and invest it elsewhere. Likely, the stock will completely tank when March 2020 comes.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Adam Othman has no position in any of the stocks mentioned. The Motley Fool recommends CannTrust Holdings and CannTrust Holdings Inc.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »